Alerta De Seguridad para HeartStart XL+ Defibrillator/Monitor

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Philips Medical Systems.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2015-07-06
  • Fecha de publicación del evento
    2015-07-06
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: philips medical systems heartstart xl+ defibrillator/monitor the australia therapeutic goods administration (tga) has posted a medical device safety alert concerning philips heartstart xl+ defibrillator/monitor manufactured by philips medical systems. the affected heartstart xl+ defibrillator/monitor units include serial numbers within the following ranges: uso1100100 to usd1101095 us11201096 to usd1203968 us11303969 to usd1309471 us11409472 to us61414022 the manufacturer has identified the following xl+ software and hardware issues:- software issues: the xl+ may fail to complete the power on sequence and continuously reboot. the xl+ may either fail to power up or may shut down unexpectedly. the xl+ may have a software version that did not reset a fail-safe monitoring component which could delay of therapy or pacing interruption. the xl+ may fail to generate verbal prompts in automated external defibrillator (aed) mode. hardware issues: the xl+ may have been manufactured with a speaker that may fail. the battery may not seat properly causing the xl+ to shut down unexpectedly or remain powered on and not acknowledge or charge the battery. the xl+ exceeds the allowable radiated emissions level for class b cispr11. the xl+ ecg signal from leads could be lost and unrecoverable. the xl+ spo2 signal may lose communication and cause the device to reboot. the xl+ battery detection system may be disrupted and cause a false low battery alarm according to the alert, the manufacturer will contact customers with affected devices to arrange for installation of the software and hardware upgrades. in the interim, the manufacturer advises users that they can continue to use their xl+ prior to receiving the software and hardware upgrades, provided they should identify a readily available backup defibrillator to use in the event the affected heartstart xl+ exhibits any of these issues. for details, please refer to the tga website: http://apps.Tga.Gov.Au/prod/sara/arn-detail.Aspx?k=rc-2015-rn-00588-1 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 6 july 2015.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: [6 Jul 2015] Philips Medical Systems HeartStart XL+ Defibrillator/Monitor
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Source
    DH